Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma.
Chatterjee
M
M
Markey Cancer Center, University of Kentucky, Lexington 40536.
Mrozek
E
E
Vaickus
L
L
Oseroff
A
A
Stoll
H
H
Russell
D
D
Kohler
H
H
Foon
K A
KA
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008213:Lymphocyte Activation; D016410:Lymphoma, T-Cell, Cutaneous / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal